Nucleic Acid Aptamers as Stabilizers of Proteins: The Stability of Tetanus Toxoid

[1]  D. Kalonia,et al.  Opposite Effects of Polyols on Antibody Aggregation: Thermal Versus Mechanical Stresses , 2012, Pharmaceutical Research.

[2]  N. Jain,et al.  Stabilization of tetanus toxoid formulation containing aluminium hydroxide adjuvant against agitation. , 2012, International journal of pharmaceutics.

[3]  J. O’brien.  Advancing vaccinology in India , 2012, Expert review of vaccines.

[4]  Xiaobing Zhang,et al.  Molecular aptamers for drug delivery. , 2011, Trends in biotechnology.

[5]  R. Karimov,et al.  A mid-term assessment of progress towards the immunization coverage goal of the Global Immunization Vision and Strategy (GIVS) , 2011, BMC public health.

[6]  Yong Wang,et al.  Affinity hydrogels for controlled protein release using nucleic acid aptamers and complementary oligonucleotides. , 2011, Biomaterials.

[7]  N. Jain,et al.  Stabilization of tetanus toxoid formulation containing aluminium hydroxide adjuvant against freeze-thawing. , 2011, International journal of pharmaceutics.

[8]  Ioannis Xenarios,et al.  T-Coffee: a web server for the multiple sequence alignment of protein and RNA sequences using structural information and homology extension , 2011, Nucleic Acids Res..

[9]  B. Seong,et al.  Chaperoning Roles of Macromolecules Interacting with Proteins in Vivo , 2011, International journal of molecular sciences.

[10]  N. Jain,et al.  Accelerated Stability Studies for Moisture-Induced Aggregation of Tetanus Toxoid , 2011, Pharmaceutical Research.

[11]  D. Bunka,et al.  Development of aptamer therapeutics. , 2010, Current opinion in pharmacology.

[12]  L. Cerchia,et al.  Targeting cancer cells with nucleic acid aptamers. , 2010, Trends in biotechnology.

[13]  Kai Griebenow,et al.  Moisture-induced solid state instabilities in α-chymotrypsin and their reduction through chemical glycosylation , 2010, BMC biotechnology.

[14]  Debra Kristensen,et al.  Stabilization of vaccines: Lessons learned , 2010, Human vaccines.

[15]  Yong Wang,et al.  Hydrogel functionalization with DNA aptamers for sustained PDGF-BB release. , 2010, Chemical communications.

[16]  Koji Sode,et al.  Screening and Improvement of an Anti-VEGF DNA Aptamer , 2010, Molecules.

[17]  Andrew R Fox.  Biosimilar Medicines—New Challenges for a New Class of Medicine , 2009, Journal of biopharmaceutical statistics.

[18]  R. J. Solá,et al.  The relation between moisture‐induced aggregation and structural changes in lyophilized insulin , 2009, The Journal of pharmacy and pharmacology.

[19]  G. Kresse.  Biosimilars--science, status, and strategic perspective. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[20]  M. H. D. da Costa,et al.  Evaluation of a diphtheria and tetanus PLGA microencapsulated vaccine formulation without stabilizers. , 2009, Current drug delivery.

[21]  B. Seong,et al.  RNA-mediated chaperone type for de novo protein folding , 2009, RNA biology.

[22]  B. V. D. van der Zeijst.  Vaccines and global stability: achievements and challenges , 2008, Expert review of vaccines.

[23]  B. V. D. Zeijst.  Vaccines and global stability: achievements and challenges , 2008 .

[24]  Wenlei Jiang,et al.  Stabilization of tetanus toxoid encapsulated in PLGA microspheres. , 2008, Molecular pharmaceutics.

[25]  B. Seong,et al.  Protein Solubility and Folding Enhancement by Interaction with RNA , 2008, PloS one.

[26]  U. Hahn,et al.  Aptamers to Small Molecules , 2006 .

[27]  Robert C. Edgar,et al.  Multiple sequence alignment. , 2006, Current opinion in structural biology.

[28]  B. Narasimhan,et al.  Protein stability in the presence of polymer degradation products: consequences for controlled release formulations. , 2006, Biomaterials.

[29]  T. Nagai,et al.  Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[30]  A. Pardi,et al.  A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Harald Schumny,et al.  Next generation , 2005, Comput. Stand. Interfaces.

[32]  H. Schellekens.  Follow-on biologics: challenges of the "next generation". , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[33]  Anubhav Jain,et al.  Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres. , 2005, International journal of pharmaceutics.

[34]  R. Landgraf,et al.  Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[35]  D. Draper,et al.  The linkage between magnesium binding and RNA folding. , 2002, Journal of molecular biology.

[36]  Chung C. Hsu,et al.  Effect of Moisture on the Stability of a Lyophilized Humanized Monoclonal Antibody Formulation , 2001, Pharmaceutical Research.

[37]  V. Uversky,et al.  Evidence for a Partially Folded Intermediate in α-Synuclein Fibril Formation* , 2001, The Journal of Biological Chemistry.

[38]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[39]  Wenlei Jiang,et al.  Formaldehyde-mediated aggregation of protein antigens: comparison of untreated and formalinized model antigens. , 2000, Biotechnology and bioengineering.

[40]  D. Patel,et al.  Adaptive recognition by nucleic acid aptamers. , 2000, Science.

[41]  A. Klibanov,et al.  The secondary structure and aggregation of lyophilized tetanus toxoid. , 1996, Journal of pharmaceutical sciences.

[42]  R. Gupta,et al.  Stabilization of tetanus and diphtheria toxoids against moisture-induced aggregation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[43]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[44]  G. Hermanson,et al.  Immobilized Affinity Ligand Techniques , 1992 .

[45]  H. Aggerbeck,et al.  Detoxification of diphtheria and tetanus toxin with formaldehyde. Detection of protein conjugates. , 1992, Biologicals : journal of the International Association of Biological Standardization.

[46]  P. K. Smith,et al.  Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.

[47]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[48]  S. Tope,et al.  Aptamers as therapeutics , 2013 .

[49]  Joan W. Miller,et al.  Controlled delivery of the anti-VEGF aptamer EYE001 with poly(lactic-co-glycolic)acid microspheres. , 2003, Investigative ophthalmology & visual science.